New York, United States
Echolight is a high-tech biomed company founded in 2010 and headquartered in the United States. The company's slogan, "Bone Identity - Bone Health Monitoring throughout life. Discover the most advanced radiation-free technology," underscores its focus on developing innovative technologies in the medical device arena. Echolight's mission is to provide the global medical community with the first radiation-free and office-based solution for early diagnosis of osteoporosis. The company is in compliance with industry standards and holds certifications such as UNI CEI EN ISO 13485: 2016, UNI EN ISO 9001: 2015 Quality Management System, CE Mark, FDA Clearance, and other major certifications worldwide for its innovative solutions in the healthcare industry.
Although specific details about recent investments and investors are not available, Echolight's dedication to advancing radiation-free technology for medical diagnosis presents an intriguing proposition for potential venture capital interest. The company's commitment to addressing critical healthcare needs while adhering to international standards positions it as a potential candidate for investment within the health tech sector.
